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Abstract
Background: Clinical free-text data (eg, outpatient letters or nursing notes) represent a vast, untapped source of rich information
that, if more accessible for research, would clarify and supplement information coded in structured data fields. Data usually need
to be deidentified or anonymized before they can be reused for research, but there is a lack of established guidelines to govern
effective deidentification and use of free-text information and avoid damaging data utility as a by-product.
Objective: This study aimed to develop recommendations for the creation of data governance standards to integrate with existing
frameworks for personal data use, to enable free-text data to be used safely for research for patient and public benefit.
Methods: We outlined data protection legislation and regulations relating to the United Kingdom for context and conducted a
rapid literature review and UK-based case studies to explore data governance models used in working with free-text data. We
also engaged with stakeholders, including text-mining researchers and the general public, to explore perceived barriers and
solutions in working with clinical free-text.
Results: We proposed a set of recommendations, including the need for authoritative guidance on data governance for the reuse
of free-text data, to ensure public transparency in data flows and uses, to treat deidentified free-text data as potentially identifiable
with use limited to accredited data safe havens, and to commit to a culture of continuous improvement to understand the relationships
between the efficacy of deidentification and reidentification risks, so this can be communicated to all stakeholders.
Conclusions: By drawing together the findings of a combination of activities, we present a position paper to contribute to the
development of data governance standards for the reuse of clinical free-text data for secondary purposes. While working in
accordance with existing data governance frameworks, there is a need for further work to take forward the recommendations we
have proposed, with commitment and investment, to assure and expand the safe reuse of clinical free-text data for public benefit.
(J Med Internet Res 2020;22(6):e16760) doi: 10.2196/16760
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Introduction
Background
Structured electronic health records (EHRs) have long been
used in large-scale research to create new knowledge to inform
clinical care, practice, and policy. There are many enterprises
specializing in making EHR data available in accordance with
jurisdictional legislation and governance [1-4]. We refer to
structured data as information recorded in specified forms and
fields within the EHRs. Generally, clinical data are highly
personal and sensitive and, therefore, need to be deidentified
or anonymized before they can be used for any secondary
purposes outside the clinical environment. We refer to
deidentified data as records from which the commonly
recognized identifiers (eg, name, address, and date of birth)
have been removed and anonymized data as information from
which the data subject cannot be identified [5]. EHR data also
contain free-text components, including notes made at
consultations and referral letters, which, by definition, are
unstructured. As such, they tend to be less available beyond the
immediate setting and are typically not readily available for
secondary uses such as research or service improvement.
However, clinical free-text data represent a vast, untapped
source of rich information to guide research and clinical care,
including patient-specific context and details that clarify and
supplement information coded in structured data fields.
Furthermore, some clinical information in mental health,
pathology, and imaging reports is not available in coding
structures but only in free-text form. By their nature, free-text
data are highly likely to contain sensitive information and patient
identifiers, and this must be suitably processed to protect
individual privacy before the information can be shared further.
The key difficulty is that there are major challenges in finding
effective methods to deidentify free-text on a scale that does
not damage data utility as a by-product.
Methods from natural language processing (NLP) have been
developed to automatically scan clinical free-text data to identify
potential identifiers, such as patients’ names, significant dates,
and their family members. There are generally 2 approaches to
automated deidentification. In a method referred to as
blacklisting, deidentification algorithms remove identifying
information so that these variables are masked in the data
extract. Alternative methods focus only on isolating the relevant
clinical information from personal identifiers via extraction of
specified variables such as medication dosage instructions or
diagnoses, which are whitelisted and preserved in text.
Whitelisting can be thought of as the converse of blacklisting
in that it extracts clinically informative data rather than
excluding disallowed pieces of information [6-8].
Each method has advantages and disadvantages and many
permutations within them. For example, blacklisting can result
in some personal identifiers remaining within deidentified text
or important nonidentifiable data being removed from the text
if the process is too stringent. Conversely, whitelisting can result
in valuable data being left behind or false information being
extracted inadvertently. Whitelisting also relies on a data
extraction algorithm to choose the relevant clinical information,
if no human is to see the identifiable data. A synthetic clinic
letter is shown in Figure 1 to illustrate some of these challenges.
As can be seen, a clinic letter can contain a variety of identifiable
information about the patient and their care providers. Accuracy
and the resulting privacy and utility in preparing free-text
extracts for reuse depends on the sophistication of the
methodologies in use. We provide some simple example
problems for illustration purposes. Blacklisting could result in
some personal identifiers remaining within purportedly
deidentified text, for example, names that are also common
words—Green and Verb. Conversely, whitelisting can leave
valuable data behind, for example, parietal polymicrogyria
without the word suggestive or pathology to explain the
hemispasms without extracting the word no. There is much
natural language processing and other methodological work
underway to enable the creation of extracts that retain data utility
and protect privacy. It is important to note that deidentification
and extraction algorithms do not work out of the box but often
have to be built and tested on specific data annotated by
domain-specific experts to train and develop the algorithms. In
general, algorithms can be trained to work to a standard
comparable with that of a human annotator, but accuracy can
decrease with increasing information complexity [6-8].
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Figure 1. Synthetic clinic letter.
Being able to create free-text extracts that do not contain
identifying information with a high degree of confidence is a
fundamental issue but is not the only consideration for the
governance of clinical free-text data. In addition, there are issues
such as regulatory approvals including independent ethics
committee review, working with or within the health service,
accessing identifiable data for the deidentification and extraction
process, engaging with clinicians to understand clinical concerns
and point of care issues, patient involvement, questions around
patient consent, retaining the ability for data linkage, and
conditions and environments for data reuse.
Main Aim
In recognition of these challenges, the main aim of this study
was to develop recommendations for the creation of data
governance standards to integrate with existing frameworks for
personal data use, to enable free-text data to be used safely for
research for patient and public benefit. As such, it will form a
position paper and inform further work. In this context, we
define safely as where the identity of the individual is highly
unlikely to be discovered. We refer to this study as TexGov. It
focuses on data governance and health services within the United
Kingdom, but the main findings are applicable more widely.
Methods
Study Design
TexGov was designed to cover a variety of activities to develop
data governance standards for using clinical free-text data in
research. It included an outline of the UK data protection
landscape for context, a rapid literature review on governance
aspects in previous UK research studies using clinical free-text
data, UK case studies with systems providing access to free-text
data for more in-depth information, engagement with researchers
to explore barriers and solutions in working with free-text data,
and engagement with the public for views on socially acceptable
approaches. These activities are described in the following
sections.
Data Protection Landscape
We reviewed the relevant legislation, regulations, and official
guidance in place in the United Kingdom for context on
governance aspects for the use of free-text data. This included
the UK Data Protection Act (DPA) 2018 [9], the European
Union General Data Protection Regulation (GDPR) 2016 [5],
the Human Rights Act [10], the common law duty of
confidentiality (CLDC [11]), the Caldicott Principles [11], and
the Information Commissioner’s Office guidance on data sharing
and anonymization [12,13].
Free-Text Data Governance Practice
We gained information on data governance in working with
clinical free-text data by carrying out a rapid literature review
[14] and mini-case studies of systems making deidentified
free-text data available for research in the United Kingdom.
The methodology for the literature review is given below:
Search Strategy
Searches for studies indexed in PubMed and Web of Science
(WoS) were conducted on January 15, 2019, using the following
search terms: (1) “electronic health records” or “electronic
medical records” or “electronic patient records” or “hospital
records” or “personal health records” or “computerized patient
records” or “computerized medical records” combined with (2)
“text mining” or “natural language processing” or “free text”
or “narrative.” Given our sole interest in ethical and governance
procedures in the United Kingdom, the search was then
restricted to papers using UK databases containing free-text
data by using the following terms: “UK” or “United Kingdom”
or “Britain” or “England” or “Wales” or “Ireland” or “Scotland.”
The search was limited to human studies published in English.
No restrictions were imposed on the year of publication.
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Eligibility
To be eligible for this review, published research had to meet
the following criteria: primary research using free-text records;
UK-based health databases or data from UK hospitals; and
information extracted from the text of (human, not veterinary)
electronic medical records, medical letters or medical reports,
and methods papers (eg, development or description of search
and analytic tools), but only if the paper used patient data in the
study.
Data Extraction
Characteristics of the included studies were extracted by one
researcher and reviewed by another researcher and were as
follows: (1) year published and lead author institution, (2) broad
purpose of the study, (3) what and where data were accessed,
(4) focus of free-text data, (5) whether the data were accessed
in identifiable form, (6) whether the study used the health
records in conjunction with other data, (7) main finding or
conclusion, and (8) any ethics and governance detailed. We will
focus on data governance aspects only, rather than the clinical
value of using free-text data.
Case Studies
The case studies were conducted through face-to-face or
telephone interviews in February 2019 and were structured to
capture information about the main model for making data
available, types of data included, data linkage capability,
free-text deidentification or extraction method, and governance
approvals. Notes were taken during the interviews and
subsequently checked for accuracy with each interviewee.
Engagement With Clinical Text-Mining Researchers
We held a 1-day workshop (January 16, 2019) for clinical
free-text mining researchers to explore their perceptions of
barriers and solutions in working with free-text data for sharing
outside the clinical setting. Participants were recruited via
advertisements on the Healtex website. The workshop was
attended by 44 people and included outlines of the TexGov
study aims, the findings of a previous citizens’ jury on using
clinical free-text data for research [15], and data protection.
These were followed by presentations from the NLP community
on their approaches to working with clinical free-text data,
during which the audience was asked to write down the topics
to discuss in more detail. The identified topics were grouped
into 4 themes and used in group discussions on challenges and
solutions: (1) patient involvement at identifiable and deidentified
data stages, (2) opt-in/opt-out consent models for the reuse of
free-text data, (3) working with identifiable data for NLP
algorithm development, and (4) deidentification methods and
thresholds of reliability. Delegates were randomly allocated to
one of the groups but were allowed to change to another if they
felt strongly about a particular topic. Each of the discussions
was facilitated and noted to capture views on the nature of the
challenge, what can be done to address it, and how that can be
achieved.
Engagement With the Public
We discussed the TexGov study with 2 public groups. The first
event was advertised to the general public and patient interest
groups by the Alan Turing Institute and held at their premises
on March 28, 2019, attended by approximately 50 people. It
included a presentation on the TexGov study and a role-play
exercise to illustrate how clinical free-text data are collected at
a hypothetical general practitioner (GP) consultation and to
engage the audience in discussion. It also included a panel
discussion so the audience could ask questions to the
representatives from the National Data Guardian’s office [16];
Understanding Patient Data, an independent patient data
taskforce [17]; use MY Data, a movement of patients, carers,
and relatives in support of using patient data [18]; and National
Health Service (NHS) England [19]. Notes were taken during
the panel discussion. This was followed by facilitated and noted
group discussions on the topics of (1) Transparency and patient
choice in the use of free-text data: what information do patients
need and which are the best methods of dissemination? (2)
Identifiability, deidentification, and anonymization: what is the
best approach to making data available? and (3) Data access
models and security in working with free-text data: how to
balance restricting and facilitating access to data? These topics
were prioritized from issues for discussion identified by
registered delegates in advance of the workshop.
The second public engagement activity was conducted with the
consumer panel based at Swansea University on May 1, 2019.
This panel is made up of 18 members of the general public, and
it advises on developments in the use of person-based data for
research, such as via the Secure Anonymised Information
Linkage (SAIL) Databank [20]. Following a description of the
TexGov study and the preliminary findings, there was an open
discussion so that members of the panel could provide their
views on the work and the publicly acceptable way forward for
the reuse of free-text data. Notes were taken on the views of the
panel members.
Results
Data Protection Landscape
The Human Rights Act provides overarching legislation, with
Article 8 setting out rights to enjoy a private life free of intrusion
and interference, subject to restrictions in accordance with law
in a democratic society [10]. Our review of UK statutory data
protection law in the DPA [9] and the GDPR [5] showed that
free-text data are not singled out by these instruments: the
provisions apply to free-text data in the same way as any general
person-identifiable data (PID) and special category health data.
Similarly, free-text data given in confidence, such as in a
physician-patient consultation, are subject to the same CLDC
[11] principles and professional practice as for structured, coded
data. The Caldicott Principles [11] set out fundamental good
practices for the protection of information that could identify
an individual but also highlight that data sharing can be as
important as the duty to protect confidentiality. Within these
principles and in the Information Commissioner’s Office
guidance on data sharing and anonymization, there is nothing
specifically stated about free-text data (Table 1). The
requirements are for data use to be subject to an appropriate
lawful basis and for data to be processed to protect privacy
before secondary uses, unless another justification (such as
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participant consent for research) is in place. This is a challenge
for the reuse of clinical free-text data: the difficulty in being
confident (and providing evidence) that deidentification is
adequate when making claims of anonymity or minimizing the
use of personal data, so that information derived from the
unstructured format of free-text data can be safely taken forward
for reuse.
Table 1. Summary of relevant data protection landscape.
Key pointsItem
Sets out an individual’s rights to enjoy a private life free of intrusion and interferenceUK Human Rights Act
Provisions for processing general person-identifiable data and special category health dataEuropean Union General Data Protection Regula-
tion and the UK Data Protection Act
Governs the use of data given in confidence, such as in a physician-patient consultationCommon Law Duty of Confidence
Set out good practice for the protection of information that could identify an individual and the
importance of data sharing
Caldicott Principles
Provides guidance on data sharing and anonymizationInformation Commissioner’s Office
Data Governance
The search identified 45 papers from PubMed and 340 papers
from WoS, with 354 papers remaining after the removal of
duplicates. After screening abstracts and full texts, 51 studies
were defined as eligible for inclusion in the rapid review.
Medical records were accessed via 3 main databases: (1) the
Health Improvement Network (THIN) primary care database
[21,22] (N=7) [23-29], (2) South London and Maudsley NHS
Foundation Trust (SLaM) with clinical records accessed via the
Clinical Records Interactive Search (CRIS) system [30-32]
(N=16) [33-49], and (3) the Clinical Practice Research Datalink
(CPRD) [50] (N=13) [51-62]. One study used the SAIL
Databank [63]. There were 13 independent studies, which were
not associated with a data management infrastructure [64-76].
The THIN and CPRD databases contain NHS patient primary
care records, whereas the CRIS system includes clinical records
for people who have used a range of NHS mental health services
and substance misuse services in the United Kingdom. The
study that used the SAIL Databank accessed the primary care
dataset. The independent studies accessed a range of free-text
records, including from accident and emergency department,
outpatient department, intensive care, primary care, and
prescribing datasets. All records in the studies that used THIN,
CRIS, CPRD, and SAIL Databank were anonymized, and no
personal information was, therefore, available to researchers.
The independent studies were more variable depending on
specific approvals and permissions, for example, identifiable
data accessed by authorized hospital staff within an NHS
organization [64,71] or data extracted following the ethical
approval of the study [76].
All studies reporting the use of THIN noted ethical approvals,
and 3 studies also cited the overarching THIN data resource
approvals by the NHS South East Multicenter Research Ethics
Committee. All but one [48] of the studies that used the CRIS
data resource noted approval by the Oxfordshire research ethics
committee and the service user-led oversight committee study
approval, which must be granted before access to the
anonymized data is permitted. Of the 13 studies using CPRD
free-text data, 4 provided no ethical approval details [51-53,61].
All the remaining studies in this group detail some level of
ethical approval, either study approval or the resource
multicenter research ethics committee approval for all
observational research using CPRD data. The study accessing
free-text data in SAIL Databank does not cite the information
governance review panel (IGRP) approval that must have been
sought before access to SAIL data was granted [63]. Of the 13
independent studies, 7 detailed the local ethical approval process
[67-69,72,73,75,76]. One stated that ethical approval was not
necessary, as the purpose of the study was to measure service
provision retrospectively without using identifiable patient
information [74], and the remaining 7 studies did not mention
ethical approvals [64-66,70,71].
None of the 7 studies that used THIN detailed the data access
model, which could have been via a sublicense agreement
enabling access for a defined period to conduct unlimited
studies, subject to protocol approval, or release of data extracts
consisting of subsets of raw data in accordance with researchers’
study protocols and specifications. CRIS is accessed within the
NHS system by researchers at the Maudsley Biomedical
Research Centre; as such, most lead authors (or at least one
coauthor) of the 16 studies using SLaM clinical records were
based at King’s College Hospital. Some, but not all, studies
specify this access route. CPRD (formally known and referenced
in studies as the General Practice Research Database) operated
on a data release model under the strict CPRD and data control
terms. Few of the retrieved studies specified this model. The
study using free-text records in the SAIL Databank did not detail
the access route, that is, following necessary governance
approvals and safe researcher training, data can be accessed
remotely within the safe haven with no external data release
[77]. The 13 independent studies provided very little information
on how data were accessed. A summary of key information
from the rapid review is given in Table 2.
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Table 2. Key information from the literature review.
Ethical approvalUse of identifiable dataLinkage to additional
datasets
Free-text searchStudyInstitute
THIN data resource ap-
proved by NHS South
Yes: [26]; all others: noYes: [23,25,27,28]; no:
[24,26,29]
[23] cause of death; [24] ischemic
cerebrovascular events; [25] diabetic
retinopathy and diabetic maculopa-
[23-29]THINa (n=7)
East Multicenter Re-
thy diagnoses; [26] child maltreat- search Ethics Commit-
teement; [27] colorectal cancer record-
ing; [28] endometriosis diagnosis;
and [29] major malformations and
comments assigned to referrals to
specialists
CRIS approved for sec-
ondary analysis by the
NoYes: [39,42,45][33] smoking status; [34] extrapyra-
midal side effects and adverse drug
[33-49]CRISb (n=17)
Oxfordshire Researchevents; [35] antipsychotic
Ethics Committee. Apolypharmacy; [36] negative symp-
service user-led over-toms of schizophrenia; [37] mood
sight committee consid-instability; [38] cannabis use; [39]
ers all proposals beforemedication descriptions; [40] char-
access to theacteristics of people with Alzheimer
anonymized data is per-
mitted
disease; [41] delivery of cognitive
behavioral therapy for psychosis;
[42] notes and correspondence on
diagnoses of mental disorders; [43]
adverse drug events; [44] symptoms
of severe mental illness; [45] risk
factors for depression; [46] presence
of negative symptoms and antipsy-
chotic use; [47] suicide ideation and
attempts; [48] information on hepati-
tis C and HIV; and [49] registered
company addresses
Multicenter research
ethics committee ap-
NoYes: [51-53]; no: [54-62][51] heart defects; [52] congenital
malformations; [53] pregnancy out-
[51-62]CPRDc (n=13)
proval was in place forcomes; [54] ovarian cancer diag-
all observational re-noses; [55] cause of death; [56]
search using CPRD da-
ta
coronary angiogram results; [57]
keywords for rheumatoid arthritis;
[58] markers for rheumatoid arthri-
tis; [59] disease-modifying an-
tirheumatic drugs; [60] records of
visible hematuria, jaundice, or ab-
dominal pain; [61] drug usage val-
ues and administrations; and [62]
terms indicating allergic bronchopul-
monary aspergillosis cases
Ethical approval is not
required for the use of
NoNo[63] symptoms of ankylosing
spondylitis
[63]SAILd (n=1)
anonymized data within
SAIL. An independent
information governance
review panel assesses
all proposed uses of
SAIL data.
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Ethical approvalUse of identifiable dataLinkage to additional
datasets
Free-text searchStudyInstitute
Variable depending on
particular study
Yes: [64,71,73,76]; no:
[67-69,72,74,75]; and
not clearly stated:
[65,66,70]
Yes: [68,69,76]; no:
[64-67], [70-75]
[64] string “asth” for asthma; [65]
range of clinical terms; [66] reason
for admission; [67] test results for
stages 3-5 chronic kidney disease;
[68] search in reports of CTe scan
of brain for stroke; [69] search in
reports of CT scan of brain for
stroke, subarachnoid hemorrhage,
or ischemic stroke; [70] keywords
on hearing aid decisions; [71] rea-
sons for dose omissions; [72] rea-
sons for deaths due to unsafe care;
[73] breathlessness and wheeze
symptoms; [74] focal liver lesions;
[75] cardiology information; and
[76] clinician discourses compared
with patient narratives
[64-76]Independent studies
(n=13)
aTHIN: The Health Improvement Network.
bCRIS: Clinical Records Interactive Search.
cCPRD: Clinical Practice Research Datalink.
dSAIL: Secure Anonymised Information Linkage.
eCT: computed tomography.
Table 2 summarizes the key information reported in the studies
included in the rapid literature review. The first column shows
the number of studies relating to each institute. The study
numbers in subsequent columns are as per the reference list
(and are not counts of studies). The extent to which individual
studies reported approvals was variable, although (at least for
those attached to THIN, CRIS, CPRD, or SAIL) they would
have had to abide by the mechanisms in place before data access
was granted because access is under institutional control. Rather
than attempting to include all details by study, we showed the
standard approvals in the final column with fuller information
in the text.
The interviews provided further information on systems
providing access to data derived from clinical free-text sources.
The purpose was to learn about their methods and from their
experiences. We do not describe the models in full detail, as
that would be beyond the scope of this paper. The THIN
database was created in 2003 by In Practice Systems (Vision).
THIN is a primary care data repository with the capability to
extract free-text as well as structured data from GP practices,
but currently, only structured data are released to external
researchers. THIN has collaborated with University College
London (UCL) to promote academic use of the data. As part of
this, a copy of the THIN database will sit in a UCL data safe
haven, which can be accessed by UCL researchers. THIN is
seeking ethical approval to enable the use of the free-text data
for academic research within UK academic or NHS safe havens.
Free-text data will be subjected to an automated deidentification
process using a blacklisting method. The full data governance
model at UCL is in the final stages of development at the time
of writing. THIN is overseen by an advisory committee
involving patient, clinician, and researcher representatives, and
all studies are reviewed by a scientific review committee before
data access can be granted [21,22].
CRIS is a medical record inquiry program that has been
implemented in a number of mental health trusts. Our example
relates to SLaM, and so, we refer to CRIS at SLaM because
other NHS Trusts might not operate CRIS under exactly the
same principles. Data are held in a repository inside the Trust
firewall (ie, in the same domain as the original health record),
which comprises a database of structured and free-text mental
health records that are deidentified, but linkable at the individual
level, before entering the repository. Unlike some blacklisting
algorithms that rely on a lexicon to ascertain and remove names,
the CRIS deidentification algorithm has access to individual
health records and makes reference to this to blank out the name
of the patient. CRIS at SLaM has ethical and s251 approval:
the latter for occasions when PID need to be exported outside
the firewall to enable linkage. It also has approval from the
Trust Caldicott Guardian and the executive board. The person
accessing the data in the safe haven must have a SLaM contract,
a SLaM honorary contract, or a research passport (an
accreditation issued by the Health Research Authority [78]).
All projects must include at least one member of the study team
who has an honorary or substantive SLaM contract and can act
as a guarantor [30-32].
SAIL is a repository that holds multiple health and wider
administrative datasets in a deidentified form about the
population of Wales. SAIL Databank does not process PID but
uses a trusted third party to receive the PID and carry out a
matching and deidentification process, with the creation of a
consistent identifier unique for each person represented to enable
individual-level linkage across datasets. Further controls are
enacted to provide access to data for research in anonymized
form within a safe haven. The SAIL data comprise extracts of
structured, coded data, with minimal free-text data at present.
However, work is underway to incorporate free-text data so that
they can be included in studies when needed. Unlike approaches
that deidentify free-text data (blacklist) and incorporate the
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remainder, the algorithm used by SAIL extracts medical terms
and descriptors (whitelist) at the NHS source for incorporation
so that only nonidentifiable structured data leave the
organization. SAIL Databank took this approach because of the
risks of introducing insufficiently deidentified information into
the databank. Working with free-text data at source is by means
of an NHS honorary contract [8], and all proposals to use SAIL
data must have received approval from an independent IGRP
before access can be granted via the data safe haven [77].
CPRD operates on a data release model and used to collect and
release deidentified (blacklisted) free-text data under strictly
controlled protocols. However, this was discontinued in 2013
on advice from the Information Commissioner’s Office, and
the catalog of free-text data was destroyed. At present, CPRD
has no plans to develop NLP or an automated text
anonymization service. Instead, they liaise directly with GPs
on behalf of researchers to validate codes to supplement coded
data with additional information.
Engagement With Clinical Text-Mining Researchers
A summary of the information gained during the discussions
on each theme is shown below in relation to the nature of the
challenge, what could be done to address it, and how this could
be achieved.
Patient Involvement at Identifiable and Deidentified
Data Stage
This theme relates to the principles of engagement with the
public for good research practice in general.
Nature of the Challenge
Delegates felt that there was a challenge in balancing what could
be perceived as a lack of individual choice in nonconsented data
cohorts with the risk of selection bias in consented cohorts,
particularly if there is doubt about the level of knowledge among
individuals, including conceptual differences between coded
and free-text data.
What Can Be Done
Additional public engagement in free-text research was seen as
needed. This should be linked with wider information about
patient data uses to help people better understand the issues and
gain their input. This could contribute to a checklist of
recommendations for researchers using free-text data, so the
public views on the use of free-text data are taken into account.
How It Can Be Achieved
Public panels and existing groups can help clarify reasonable
expectations regarding the use of free-text data. It would be
useful to have a repository of findings from research using
free-text data showing its clinical benefits. This could also
include information in lay format on advances in methodological
research to improve processes of handling free-text data.
Opt-In/Opt-Out Consent Models for Reuse of Free-Text
Data
This theme relates to managing individual choices in the use of
free-text data for research.
Nature of the Challenge
Discussions focused on the need to convey a reasonable
understanding of the motivations, risks, and benefits of
researchers accessing free-text data and how data reuse is
governed. In particular, the challenge of providing appropriate
consent options was highlighted.
What Can Be Done
As consent might not be required, or even be possible, for
processing large-scale free-text data across populations,
delegates stressed the need for guidance and good practice on
free-text data reuse in line with governance requirements and
expectations.
How It Can Be Achieved
A wider examination of existing practice used by government
departments along with clinical and regulatory codes of practice
would provide further guidance on how to manage consent
options. Possible solutions could be piloted and evaluated for
practicality.
Working With Identifiable Data for Natural Language
Processing Algorithm Development
This theme relates to the practicalities in accessing free-text
data in identifiable form to prepare extracts for research.
Nature of the Challenge
Free-text data are needed in their original (raw) form for
effective NLP algorithm development and maintenance, yet the
data are identifiable, and some contain sensitive information.
In addition, the free-text datasets accessed need to be of
sufficient scale to avoid introducing bias when developing NLP
methods.
What Can Be Done
There is a need to clarify whether enabling data access via a
safe haven can provide a suitable solution, if patient data can
be used without consent for the purpose of training algorithms,
and the usefulness of publicly available datasets.
How It Can Be Achieved
Delegates suggested possible solutions by creating a Text Bank
to support NLP development via data donation, the use of
synthetic datasets, and sharing annotated free-text data with
other developers.
Deidentification Methods and Reliability Thresholds
This theme relates to residual reidentification risk and data
utility in the datasets used for research.
Nature of the Challenge
Delegates focused on the challenges in quantifying the residual
risk of reidentification in free-text data extracts, particularly in
the face of the high degree of data variability and the absence
of a gold standard threshold for free-text deidentification.
What Can Be Done
Discussions highlighted the need for robust security with only
trusted access and an audit trail, and that free-text data extracts
should be treated as potentially identifiable. More research on
the relationship between the accuracy of the deidentification
J Med Internet Res 2020 | vol. 22 | iss. 6 | e16760 | p. 8http://www.jmir.org/2020/6/e16760/
(page number not for citation purposes)
Jones et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
algorithm, risk of reidentification, and data utility was identified
as a need.
How It Can Be Achieved
Accessing free-text data extracts only within safe havens by
small teams embedded within organizations, and with clear
lines of accountability, was seen as a positive step. A range of
risk models should be employed to avoid overscrubbing the
data with consequent loss of data utility and to determine
acceptable levels of deidentification.
Engagement With the Public: Panel Discussions at the
Turing Institute Event
The panel discussion at the Turing Institute event with
representatives from the National Data Guardian’s office,
Understanding Patient Data, use MY Data, and NHS England
raised some important points. The National Data Guardian
representative highlighted that data protection legislation is not
a barrier to data sharing, but there is a need for proper
transparency and trustworthiness to build public confidence. In
addition, there is a need for a joined-up approach in developing
consistent standards, language, and message. The representative
from understanding patient data stressed the huge potential in
being able to use clinical free-text data beyond direct care but
also highlighted the challenges in being able to enact this in an
acceptable way, respecting privacy and ensuring accuracy in
data extracted. They also spoke of the need for evidence of the
potential benefits to patients of the use of their clinical free-text
data. The representative from use MY Data emphasized the
enormous potential of, as yet, largely underutilized free-text
data for research purposes, seeing this as an atrocious waste.
This was accompanied by an expression of the need for ongoing
patient engagement and that use MY Data is an instruction, not
a request, as the group wants greater use of patient data and is
working hard to convey this message to decision makers. The
NHS England representative spoke about the CLDC and the
need for free-text data use not to impact the confidentiality of
medical consultations. All the panelists emphasized the need
to demonstrate to the public the benefits of using clinical
free-text data and the importance of working in accordance with
existing research and information governance frameworks, but
that adaptations to these frameworks may be required for
emerging data types and formats.
Engagement With the Public: Group Discussions at
the Turing Institute Event
A summary of the points emerging from the group discussions
with delegates at the Turing Institute event is provided in
relation to knowledge gaps, involvement and engagement, and
suggested solutions.
Transparency and Patient Choice in the Use of Clinical
Free-Text Data: What Information Do Patients Need
and Which Are the Best Methods of Dissemination?
Knowledge Gaps
The delegates acknowledged the efforts that go into public
involvement and engagement but highlighted the seldom heard
voices, such as hard to reach groups, marginalized groups, and
young people.
Involvement and Engagement
They felt that because of risks of misunderstanding, information
for the public should be layered, that is, it should be
contextualized by founding it on health data and research before
adding the particular features, risks, and benefits of free-text
data.
Suggested Solutions
Information should be provided in plain language and in
accessible formats, taking into account differing needs and
abilities. Delegates recommended tapping into patient networks
as authentic, credible ambassadors for discussions with the
wider public and the value in working with communication
experts. It was seen as important to explain that although there
are challenges in effectively deidentifying free-text data, it is a
format of data and not fundamentally different from other health
data.
Identifiability, Deidentification, and Anonymization:
What Is the Best Approach to Making Data Available?
Knowledge Gaps
The delegates felt unclear about how the GDPR (introduced in
2018) would apply within the context of the existing UK
regulations and uncertainties around how best to make data
available and minimize risks. There were uncertainties around
how one might seek informed consent to participate in research
in a way that participants would understand but also how wider
public would be able to grasp concepts in the abstract.
Involvement and Engagement
The delegates expressed the need for clearer information on the
relationship between having a lawful basis for data processing
under the GDPR and the fact that this does not negate the need
for consent to participate in research. With regard to
identifiability, delegates felt that the research community should
make a strong case for the use of free-text data in research,
including that it was important not to lose that richness.
Suggested Solutions
Delegates felt that engagement and educational events should
be carefully planned in terms of how they could empower people
to make informed decisions when it came to reusing of free-text
data. This would need to provide a compelling reason for
research to look at minimally deidentified free-text data to
preserve the richness, balanced against how the risks to
participants could be managed.
Data Access Models and Security in Working With
Free-Text Data: How to Balance Restricting and
Facilitating Access to Data?
Knowledge Gaps
Delegates acknowledged a general lack of awareness of different
data access models and the degrees to which data can be
controlled, shared, or made openly accessible. They stressed
the risks of not using the free-text data and the benefits that
could be added to research.
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Involvement and Engagement
Delegates felt that there should be more involvement and
engagement with the public to explain due diligence processes
and safeguards in managing free-text data. This should include
interactive methods and demonstrations, not limited to passive
information transfer.
Suggested Solutions
Delegates stressed that free-text data need to be used so that the
United Kingdom does not lag behind other countries. The
research community should be open to the public and explain
that deidentification of free-text data may be imperfect. Patient
groups should follow the example of use MY Data and lobbying
data controllers for free-text data to be made more accessible
to researchers.
Engagement With the Public: Consumer Panel
Having been presented with the findings of the previous
engagement activities (described here), the consumer panel
agreed and furthermore suggested that patient involvement
should be included at all stages practical in the development of
algorithms to avoid bias in relation to diversity; that involvement
should be ongoing because of societal attitudinal changes over
time and as new knowledge comes to light; and that a databank
of clinical free-text data for algorithm development would be
a good thing, provided that it is done transparently and properly
managed.
Discussion
Principal Findings
To our knowledge, this is the first study to explore the data
governance aspects for using clinical free-text data and to do
this through a combination of outlining the legislative and
regulatory backdrop, reviewing literature and systems using
free-text data extracts in health research, and gaining the
perspectives of free-text data researchers and members of the
public. In terms of UK data protection legislation and guidance,
there is nothing specific in relation to free-text data. In many
ways, this was to be expected, as legislation tends to be high
level needing interpretation and justification of an appropriate
lawful basis on how data are to be used. In addition, free-text
is a data format and not a different type or category (eg, health,
political views, and ethnicity) of data, and so, it is covered by
the data protection provisions for health data. In terms of official
guidance, such as from the Information Commissioner’s Office,
the need to properly manage and process all personal data for
reuse is addressed in codes of practice [12,13]. However, until
recently, the vast majority of routine health data made available
for secondary use was from coded records. As such, clinical
free-text data are among the emerging research datasets, such
as genomic and imaging data, and warrant further attention to
develop official guidance to simultaneously safeguard individual
privacy and maximize data utility for research in the public
interest.
Our literature review revealed a variety of published studies
that used data derived from free-text sources (eg, clinical notes
and referral letters), sometimes in conjunction with coded health
records and other datasets. The majority of these were conducted
through established systems (eg, THIN and CRIS) specializing
in making clinical free-text data available for approved research,
in accordance with their operating and governance models.
There were also some studies not associated with one of these
systems. In many cases, the authors properly reported on how
data were accessed and provided information on regulatory and
governance approvals in place. However, there was also
inconsistency and a lack of information in some studies,
although this might reflect reporting rather than practice [79].
It is not always easy to ensure that authors provide governance
details, but at least in studies from the established systems, this
is a matter for publication policies that are part of their good
governance practice. However, it should also be addressed by
journal editors to ensure that there is a section providing
transparency on methodology and data governance where
free-text data (or person-based data) have been used.
There are a variety of automated methods to deidentify or extract
data from free-text clinical documents for reuse in research or
other purposes beyond direct clinical care. Our review showed
that blacklisting methods are used by THIN and CRIS (and
previously used by CPRD) and whitelisting methods are used
by SAIL. THIN and SAIL operate in the higher education sector,
whereas CRIS operates behind an NHS Trust firewall. All 3
institutes operate a data safe haven model, rather than external
data release, and all have data governance models in place. From
engagement with clinical text-mining researchers, it is clear that
although the state-of-the-art systems achieve performance
comparable with manual deidentification, there are still
uncertainties about the efficacy of blacklisting methods and
acceptable thresholds of reliability. Further work is needed to
address this issue. However, whitelisting is not a panacea, as it
also relies on algorithms that must be tested on identifiable data
and can risk over- or underextracting data.
We have noted that using only small samples of identifiable
free-text data sources can lead to bias. The creation of a free-text
databank donated on a voluntary basis for developmental work
would help to advance this field of work. At the same time,
there is a need to minimize the need for human access to clinical
free-text data through continual improvement in technological
NLP methods for deidentification of clinical narratives. Further
developments are also needed in other areas of text processing
so that free-text data can be more efficiently converted to a
structured format before reuse. Although this is advantageous
in terms of risk minimization, it risks the loss of information
richness that could be needed for qualitative research, exploring
areas such as language, culture, and patient stories in the full
free-text data, and reduces the future possible uses of the text
data, with new extractions needed for subsequent research
studies.
The clear need for patient involvement and engagement in the
development of reusing free-text data was highlighted in the
events with researchers and the public. This included a call for
public-facing activities to be ongoing, inclusive, and transparent.
Public delegates at the Turing Institute event and the consumer
panel were generally positive about using free-text data for
research, and this is in line with previous work with the Brighton
Citizen’s Jury (in 2018). This jury suggested that people’s
concerns could be mitigated with comprehensive patient-facing
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information about how, when, and under what conditions
patients’ free-text data might be used for research. Furthermore,
patients should be involved as key stakeholders throughout all
stages of the research process. The public also expects that
researchers are committed to a culture of continuous
improvement of methods for coding, anonymizing, processing,
and safeguarding clinical free-text data [15].
Participant consent was a theme discussed at the clinical
text-mining researcher workshop and again at the Turing
Institute event, as it was at the Brighton Citizens’ Jury. There
was a recognition that it would not generally be practicable to
seek opt-in consent to incorporate deidentified free-text extracts
into data safe havens for reuse in research. The possibilities of
opt-out consent were also explored and were considered
favorable if they could be enacted in accordance with existing
patient data guidelines. In England, there is a national opt-out
where patients can choose not to have their data used for
purposes beyond their direct care. However, in practice, this
only applies to situations where the reuse of the data relies on
s251 approval to set aside the CLDC [80]. As such, it is not a
comprehensive opt-out mechanism and is not equipped to allow
someone to specify a particular data format. Working in Wales,
SAIL Databank operates its own opt-out mechanism by allowing
individuals to inform their GP that they do not wish their data
to be provided to the databank; again, this is an all-or-nothing
option. More granular optouts would present difficult challenges
in defining data content for inclusion and exclusion.
Nevertheless, the mechanisms in place do provide individuals
with choices they can exercise in relation to their patient records.
The panel discussion at the Turing Institute event stressed the
importance of operating within existing frameworks for all data,
not singling out clinical free-text data as fundamentally different.
Although challenges remain for meaningful opt-out consent,
mitigation can be provided via clear privacy notices, lawful
bases for data processing, and transparent information on
safeguards and their limitations. However, although the group
discussions highlighted the great importance of being able to
make good use of clinical free-text data, we are still left with
the situation that the deidentification (blacklisting) of free-text
data is imperfect, and extracting only certain elements
(whitelisting) produces only a study-specific data extract.
Although established data systems making free-text extracts
available in one form or another have data governance controls
in place, there are cases where further measures are needed at
the project level. Two examples are studies that are not
associated with established systems such that the data might be
subject to external release (ie, to be held outside a data
management infrastructure) and studies that need to use free-text
data for qualitative analysis, where having the data translated
into coded form would not be adequate.
Recommendations
In addition to good practice in handling person-based data in
general, we propose the following set of recommendations and
suggestions for further work to operate in accordance with, and
augment, existing research and information governance
frameworks:
• There is a need for clear regulatory guidance on data
governance for the reuse of clinical free-text data, taking
into account factors including whether the data are
deidentified through blacklisting or extracted via
whitelisting; the native data are housed at their original
source or safe havens or exported to external users, and the
extracts are in a coded or raw free-text form.
• Patients and the public should be better informed about
free-text data flows and uses, including the availability of
opt-out arrangements for the reuse of patient data for
research in accordance with jurisdictional policies. This
requires commitment from researchers and the public.
• The use of free-text data and results of studies should be
publicized to all stakeholders, but particularly patients, so
that the public can see that free-text data can bring
additional benefits. This could take the form of regularly
updated case studies in a central location, including
information about the data used and the findings of the
study.
• Further improvements are needed in deidentification and
extraction algorithms with a better understanding of the
relationships between the accuracy of deidentification and
thresholds of reidentification risk. This could be facilitated
by a national challenge with public demonstrations on how
free-text data are deidentified.
• Owing to the current uncertainties, blacklisted clinical
free-text data should be treated as potentially identifiable
and access for research restricted to accredited data safe
havens, unless a thorough review is conducted before
release.
• Organizations providing access to clinical free-text extracts
should stipulate in their publication policies a data
governance statement to be placed in publications, and
journals should require a suitable statement for all studies
using data derived from free text.
• The specifics around the creation of a databank of donated
clinical free-text data to support the construction of
deidentification and extraction of algorithms should be
explored; this would necessarily include further public
engagement and government and NHS commitment.
Limitations
We acknowledge that the TexGov study was subject to
limitations. It was a small study of a few months in duration
and, as such, could not be comprehensive in scope. It was
limited to the United Kingdom, and the governance of data use
may differ in other jurisdictions. However, we believe that the
principles will be largely applicable beyond the United
Kingdom. We were unable to engage specifically with data
providers or clinicians who created the data to gauge their
viewpoints. This could be a focus of future work.
Conclusions
It is well known that clinical free-text data represent a rich
resource for reuse in research, but that there are particular
challenges in working with unstructured data to safeguard
privacy and maximize data utility. We have shown that lessons
can be learned from established systems providing access to
data derived from clinical free text and that the views of
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text-mining researchers and members of the public provide
valuable insights. We present the new knowledge gained in this
unique study in the form of a position paper to work toward the
development of data governance standards for the reuse of
free-text data. While recognizing that free-text data are not
fundamentally different from other patient data and the need to
work within existing data governance frameworks, we propose
that there is a need to develop the TexGov recommendations,
with commitment and investment, to expand and assure the safe
use of free-text data for public benefit.
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